Literature DB >> 19274719

Structural analysis of the human cannabinoid receptor one carboxyl-terminus identifies two amphipathic helices.

Kwang H Ahn1, Maria Pellegrini, Natia Tsomaia, Achani K Yatawara, Debra A Kendall, Dale F Mierke.   

Abstract

Recent research has implicated the C-terminus of G-protein coupled receptors in key events such as receptor activation and subsequent intracellular sorting, yet obtaining structural information of the entire C-tail has proven a formidable task. Here, a peptide corresponding to the full-length C-tail of the human CB1 receptor (residues 400-472) was expressed in E.coli and purified in a soluble form. Circular dichroism (CD) spectroscopy revealed that the peptide adopts an alpha-helical conformation in negatively charged and zwitterionic detergents (48-51% and 36-38%, respectively), whereas it exhibited the CD signature of unordered structure at low concentration in aqueous solution. Interestingly, 27% helicity was displayed at high peptide concentration suggesting that self-association induces helix formation in the absence of a membrane mimetic. NMR spectroscopy of the doubly labeled ((15)N- and (13)C-) C-terminus in dodecylphosphocholine (DPC) identified two amphipathic alpha-helical domains. The first domain, S401-F412, corresponds to the helix 8 common to G protein-coupled receptors while the second domain, A440-M461, is a newly identified structural motif in the distal region of the carboxyl-terminus of the receptor. Molecular modeling of the C-tail in DPC indicates that both helices lie parallel to the plane of the membrane with their hydrophobic and hydrophilic faces poised for critical interactions. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274719      PMCID: PMC2698224          DOI: 10.1002/bip.21179

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  53 in total

1.  The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain.

Authors:  S Mukhopadhyay; H H McIntosh; D B Houston; A C Howlett
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

Review 2.  Guidelines for membrane protein engineering derived from de novo designed model peptides.

Authors:  L P Liu; C M Deber
Journal:  Biopolymers       Date:  1998       Impact factor: 2.505

3.  Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies.

Authors:  A C Howlett; C Song; B A Berglund; G H Wilken; J J Pigg
Journal:  Mol Pharmacol       Date:  1998-03       Impact factor: 4.436

4.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization.

Authors:  S Cvejic; L A Devi
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

5.  Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus.

Authors:  A Oksche; M Dehe; R Schülein; B Wiesner; W Rosenthal
Journal:  FEBS Lett       Date:  1998-03-06       Impact factor: 4.124

6.  Length analyses of mammalian G-protein-coupled receptors.

Authors:  J M Otaki; S Firestein
Journal:  J Theor Biol       Date:  2001-07-21       Impact factor: 2.691

7.  A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells.

Authors:  R Schülein; R Hermosilla; A Oksche; M Dehe; B Wiesner; G Krause; W Rosenthal
Journal:  Mol Pharmacol       Date:  1998-09       Impact factor: 4.436

8.  Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein.

Authors:  J C Bermak; M Li; C Bullock; Q Y Zhou
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

9.  Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling.

Authors:  J Lutz; R Romano-Götsch; C Escrieut; D Fourmy; B Mathä; G Müller; H Kessler; L Moroder
Journal:  Biopolymers       Date:  1997-06       Impact factor: 2.505

Review 10.  The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

Authors:  A C Porter; C C Felder
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

View more
  17 in total

1.  Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Chem Inf Model       Date:  2019-12-10       Impact factor: 4.956

2.  Hydrophobic residues in helix 8 of cannabinoid receptor 1 are critical for structural and functional properties.

Authors:  Kwang H Ahn; Akiko Nishiyama; Dale F Mierke; Debra A Kendall
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

3.  A membrane-proximal, C-terminal α-helix is required for plasma membrane localization and function of the G Protein-coupled receptor (GPCR) TGR5.

Authors:  Lina Spomer; Christoph G W Gertzen; Birte Schmitz; Dieter Häussinger; Holger Gohlke; Verena Keitel
Journal:  J Biol Chem       Date:  2013-12-13       Impact factor: 5.157

4.  Human cannabinoid 1 GPCR C-terminal domain interacts with bilayer phospholipids to modulate the structure of its membrane environment.

Authors:  Elvis K Tiburu; Sergiy Tyukhtenko; Han Zhou; David R Janero; Jochem Struppe; Alexandros Makriyannis
Journal:  AAPS J       Date:  2011-01-14       Impact factor: 4.009

5.  Binding between a distal C-terminus fragment of cannabinoid receptor 1 and arrestin-2.

Authors:  Shubhadra N Singh; Kunal Bakshi; Richard W Mercier; Alexandros Makriyannis; Spiro Pavlopoulos
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

6.  Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.

Authors:  Jahan Marcu; Derek M Shore; Ankur Kapur; Megan Trznadel; Alexandros Makriyannis; Patricia H Reggio; Mary E Abood
Journal:  J Pharmacol Exp Ther       Date:  2013-02-20       Impact factor: 4.030

Review 7.  Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.

Authors:  Slava Rom; Yuri Persidsky
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-08       Impact factor: 4.147

8.  NMR solution structure of human cannabinoid receptor-1 helix 7/8 peptide: candidate electrostatic interactions and microdomain formation.

Authors:  Sergiy Tyukhtenko; Elvis K Tiburu; Lalit Deshmukh; Olga Vinogradova; David R Janero; Alexandros Makriyannis
Journal:  Biochem Biophys Res Commun       Date:  2009-09-18       Impact factor: 3.575

9.  Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.

Authors:  Derek M Shore; Gemma L Baillie; Dow H Hurst; Frank Navas; Herbert H Seltzman; Jahan P Marcu; Mary E Abood; Ruth A Ross; Patricia H Reggio
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

10.  Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.

Authors:  Joong-Youn Shim; Leepakshi Khurana; Debra A Kendall
Journal:  Proteins       Date:  2016-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.